RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancerJohan Staaf, Johan Vallon‐Christersson, Niklas Loman et al.|npj Breast Cancer|2022Cited by 103
The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrenceSara Jansson, Lisa Rydén|Breast Cancer Research and Treatment|2018Cited by 82
St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases - aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trialAnna‐Karin Falck, Lisa Rydén|BMC Cancer|2013Cited by 74
Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiativeLisa Rydén, Åke Borg, Niklas Loman et al.|British journal of surgery|2018Cited by 64
Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical seriesJohan Vallon‐Christersson, Johan Staaf, Jari Häkkinen et al.|Scientific Reports|2019Cited by 58